共 50 条
- [41] Efficacy and safety of camrelizumab plus chemotherapy versus chemotherapy alone in patients with untreated, HER2-negative, unresectable locally advanced, or metastatic gastric cancer or gastroesophageal junction cancer: a retrospective comparative cohort study JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (06) : 2874 - +
- [44] Fibrin-Sealant-Delivered Cisplatin Chemotherapy Versus Cisplatin Hyperthermic Intraperitoneal Perfusion Chemotherapy for Locally Advanced Gastric Cancer Without Peritoneal Metastases: A Randomized Phase-II Clinical Trial with a 40-Month Follow-up CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 1171 - 1180